Search Results

There are 56648 results for: content related to: Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

  1. You have free access to this content
    Emerging strategies for exploiting cannabinoid receptor agonists as medicines

    British Journal of Pharmacology

    Volume 156, Issue 3, February 2009, Pages: 397–411, Roger G Pertwee

    Version of Record online : 17 FEB 2009, DOI: 10.1111/j.1476-5381.2008.00048.x

  2. You have free access to this content
    CB2: a cannabinoid receptor with an identity crisis

    British Journal of Pharmacology

    Volume 160, Issue 3, June 2010, Pages: 467–479, Brady K Atwood and Ken Mackie

    Version of Record online : 4 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00729.x

  3. Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

    Annals of the New York Academy of Sciences

    Volume 1074, Issue 1, August 2006, Pages: 514–536, EMMANUEL S. ONAIVI, HIROKI ISHIGURO, JIAN-PING GONG, SEJAL PATEL, ALEX PERCHUK, PAUL A. MEOZZI, LESTER MYERS, ZOILA MORA, PATRICIA TAGLIAFERRO, EILEEN GARDNER, ALICIA BRUSCO, BABATUNDE E. AKINSHOLA, QING-RONG LIU, BRUCE HOPE, SHINYA IWASAKI, TADAO ARINAMI, LINDSEY TEASENFITZ and GEORGE R. UHL

    Version of Record online : 6 SEP 2006, DOI: 10.1196/annals.1369.052

  4. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT2A) receptor activity via ERK1/2 signaling

    Synapse

    Volume 67, Issue 3, March 2013, Pages: 145–159, Jade M. Franklin and Gonzalo A. Carrasco

    Version of Record online : 8 DEC 2012, DOI: 10.1002/syn.21626

  5. Overexpression of Cannabinoid CB2 Receptor in the Brain Induces Hyperglycaemia and a Lean Phenotype in Adult Mice

    Journal of Neuroendocrinology

    Volume 24, Issue 8, August 2012, Pages: 1106–1119, S. Y. Romero-Zerbo, M. S. Garcia-Gutierrez, J. Suárez, P. Rivera, I. Ruz-Maldonado, M. Vida, F. Rodriguez de Fonseca, J. Manzanares and F. Javier Bermúdez-Silva

    Version of Record online : 5 JUL 2012, DOI: 10.1111/j.1365-2826.2012.02325.x

  6. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids

    Medicinal Research Reviews

    Volume 29, Issue 2, March 2009, Pages: 213–271, Lumír Ondřej Hanuš

    Version of Record online : 5 SEP 2008, DOI: 10.1002/med.20135

  7. You have free access to this content
    The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors

    FEBS Letters

    Volume 580, Issue 22, October 02, 2006, Pages: 5392–5398, Ntsang M. Nebane, Brandon Kellie and Zhao-Hui Song

    Version of Record online : 12 SEP 2006, DOI: 10.1016/j.febslet.2006.09.001

  8. You have free access to this content
    The endocannabinoid system as a target for the treatment of neurodegenerative disease

    British Journal of Pharmacology

    Volume 160, Issue 3, June 2010, Pages: 480–498, Emma L Scotter, Mary E Abood and Michelle Glass

    Version of Record online : 5 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00735.x

  9. You have free access to this content
    Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

    Genes, Brain and Behavior

    Volume 8, Issue 5, July 2009, Pages: 519–530, Q.-R. Liu, C.-H. Pan, A. Hishimoto, C.-Y. Li, Z.-X. Xi, A. Llorente-Berzal, M.-P. Viveros, H. Ishiguro, T. Arinami, E. S. Onaivi and G. R. Uhl

    Version of Record online : 3 JUN 2009, DOI: 10.1111/j.1601-183X.2009.00498.x

  10. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling

    Biological Reviews

    Volume 79, Issue 1, February 2004, Pages: 187–205, C. Robin Hiley and William R. Ford

    Version of Record online : 15 MAR 2007, DOI: 10.1017/S1464793103006201

  11. You have free access to this content
    Effects of cannabinoids and their receptors on viral infections

    Journal of Medical Virology

    Volume 88, Issue 1, January 2016, Pages: 1–12, Alireza Tahamtan, Masoumeh Tavakoli-Yaraki, Tomasz P. Rygiel, Talat Mokhtari-Azad and Vahid Salimi

    Version of Record online : 25 JUN 2015, DOI: 10.1002/jmv.24292

  12. You have free access to this content
    The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines

    FEBS Letters

    Volume 425, Issue 3, April 03, 1998, Pages: 419–425, J.-M Derocq, M Bouaboula, J Marchand, M Rinaldi-Carmona, M Ségui and P Casellas

    Version of Record online : 14 APR 1998, DOI: 10.1016/S0014-5793(98)00275-0

  13. The therapeutic potential of cannabinoids for movement disorders

    Movement Disorders

    Volume 30, Issue 3, March 2015, Pages: 313–327, Benzi Kluger, Piera Triolo, Wallace Jones and Joseph Jankovic

    Version of Record online : 4 FEB 2015, DOI: 10.1002/mds.26142

  14. You have full text access to this OnlineOpen article
    Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells

    Acta Physiologica

    Volume 214, Issue 1, May 2015, Pages: 63–74, L. Jean-Gilles, M. Braitch, M. L. Latif, J. Aram, A. J. Fahey, L. J. Edwards, R. A. Robins, R. Tanasescu, P. J. Tighe, B. Gran, L. C. Showe, S. P. Alexander, V. Chapman, D. A. Kendall and C. S. Constantinescu

    Version of Record online : 10 MAR 2015, DOI: 10.1111/apha.12474

  15. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

    Addiction Biology

    Volume 13, Issue 2, June 2008, Pages: 147–159, Roger G. Pertwee

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1369-1600.2008.00108.x

  16. You have free access to this content
    Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission

    The Journal of Physiology

    Volume 593, Issue 4, 15 February 2015, Pages: 871–886, Jimok Kim and Yong Li

    Version of Record online : 5 JAN 2015, DOI: 10.1113/jphysiol.2014.286633

  17. The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects

    Journal of Applied Toxicology

    Volume 33, Issue 4, April 2013, Pages: 246–264, Panagiotis Zogopoulos, Ioanna Vasileiou, Efstratios Patsouris and Stamatios Theocharis

    Version of Record online : 8 JAN 2013, DOI: 10.1002/jat.2828

  18. You have free access to this content
    Cannabinoid Receptor Activation Differentially Regulates the Various Adenylyl Cyclase Isozymes

    Journal of Neurochemistry

    Volume 71, Issue 4, October 1998, Pages: 1525–1534, Man-Hee Rhee, Michael Bayewitch, Tomer Avidor-Reiss, Rivka Levy and Zvi Vogel

    Version of Record online : 13 NOV 2002, DOI: 10.1046/j.1471-4159.1998.71041525.x

  19. Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption

    Molecular Carcinogenesis

    Volume 54, Issue 12, December 2015, Pages: 1796–1806, Rentian Feng, Qin Tong, Zhaojun Xie, Haizi Cheng, Lirong Wang, Suzanne Lentzsch, G.David Roodman and Xiang-Qun Xie

    Version of Record online : 16 JAN 2015, DOI: 10.1002/mc.22251

  20. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 6, June 2015, Pages: 885–916, Eric P. Baron

    Version of Record online : 25 MAY 2015, DOI: 10.1111/head.12570